Regeneron Pharmaceuticals, Inc.
Methods for treating or preventing asthma by administering an IL-4R antagonist

Last updated:

Abstract:

The invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods featured in the invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.

Status:
Grant
Type:

Utility

Filling date:

29 Oct 2018

Issue date:

15 Jun 2021